Christopher Galle

Christopher has served multiple roles at Bioenergy Devco, having previously served as the company’s Chief Financial Officer and Chief Operating Officer. In 2022, he was appointed as the Chief Investment Officer & Head of Investor Relations. He leads the company in acquiring new investments and the utilization of capital as the interest in anaerobic digestion project financing increases in the United States and around the globe. Additionally, he supports business development partnerships and opportunities. Before joining BDC, Mr. Galle worked in the Investment Banking Division of Barclays from 2011 to 2018, focusing on financial institutions. While at Barclays, Mr. Galle executed both M&A transactions as well as variety capital markets offerings, including debt and equity for clients. Mr. Galle also worked in Lehman Brothers Private Equity Group from 2005 to 2009, where he conducted analysis on private fund investments and direct co-investment opportunities. Before joining Lehman Brothers, he worked at Commerce Street Capital (fka SAMCO Capital Markets), advising community banks in Texas.

Mr. Galle has an MBA from Columbia Business School and a BBA with Honors from Texas Tech University.